J&J/Omrix’s Evicel Wins CHMP Recommendation
This article was originally published in The Pink Sheet Daily
Human fibrogen/thrombin product would be indicated for supportive treatment in surgery.
You may also be interested in...
Company will price the recombinant, plasma-free thrombin at a 20 percent premium over competitor King's bovine-derived Thrombin JMI.
Approval puts Evicel marginally ahead of ZymoGenetics’ recombinant human fibrin sealant rhThrombin, which has a Jan. 17 action date.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.